INSITU INHIBITION OF TYROSINE PROTEIN-KINASE BY ERBSTATIN
- 1 November 1987
- journal article
- research article
- Vol. 15 (5) , 989-995
Abstract
Erbstatin inhibited the kinase activity of the receptor for epidermal growth factor in cultured A431 cells, while it did not alter turnover of the receptor protein. It also inhibited autophosphorylation of the src gene product p60src in Rous sarcoma virus-infected normal rat kidney cells. Erbstatin did not inhibit the binding of epidermal growth factor to its receptor but did inhibit internalization of epidermal growth factor-receptor complexes. It did not inhibit the epidermal growth factor-stimulated phosphatidylinositol turnover in A431 cells. Thus, erbstatin inhibited two oncogene product-related tyrosine protein kinases in situ and thus is a useful tool to study the role of tyrosine protein kinase.This publication has 7 references indexed in Scilit:
- Evidence that the Rous sarcoma virus transforming gene product phosphorylates phosphatidylinositol and diacylglycerol.Proceedings of the National Academy of Sciences, 1984
- Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequencesNature, 1984
- Biological role of epidermal growth factor-receptor clustering. Investigation with monoclonal anti-receptor antibodies.Journal of Biological Chemistry, 1983
- Enhancement of calcium uptake and phosphatidylinositol turnover by epidermal growth factor in A-431 cellsBiochemistry, 1981
- Mechanism of tumor promoter inhibition of cellular binding of epidermal growth factorProceedings of the National Academy of Sciences, 1979
- Evidence that the transforming gene of avian sarcoma virus encodes a protein kinase associated with a phosphoproteinCell, 1978
- Properties of mammalian cells transformed by temperature-sensitive mutants of avian sarcoma virusCell, 1977